Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Sclerostin and Dickkopf-1 as therapeutic targets in bone diseases.

Sclerostin and Dickkopf-1 as therapeutic targets in bone diseases. Endocr Rev. 2012 Oct; 33(5):747-83.

View in: PubMed

© 2022 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.